David S Ettenson

Title: David S Ettenson: Innovator in Thrombin Degradation Resistant Fibroblast Growth Factor-1

Introduction

David S Ettenson is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents that can overcome challenges posed by thrombin degradation.

Latest Patents

Ettenson holds a patent for "Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1." This invention focuses on novel degradation resistant FGF-1 and methods for its production and use. The thrombin degradation resistant FGF-1 can elicit biological responses that are typically hindered by thrombin-induced degradation. This innovation is crucial for addressing diseases or disorders where an FGF-1 response can alleviate symptoms but is compromised by degradation.

Career Highlights

Throughout his career, Ettenson has worked with esteemed organizations such as the Maine Medical Center Research Institute and Repair, Inc. His work has been instrumental in advancing therapeutic strategies that leverage the unique properties of FGF-1.

Collaborations

Ettenson has collaborated with notable professionals in his field, including Thomas Maciag and Wilson H Burgess. These partnerships have contributed to the development and refinement of his innovative approaches.

Conclusion

David S Ettenson's work in developing thrombin degradation resistant fibroblast growth factor-1 represents a significant advancement in therapeutic research. His contributions continue to impact the medical field positively.